scispace - formally typeset
A

Andrew Kennedy

Researcher at University of Oxford

Publications -  6
Citations -  447

Andrew Kennedy is an academic researcher from University of Oxford. The author has contributed to research in topics: valvular heart disease & Internal medicine. The author has an hindex of 3, co-authored 4 publications receiving 263 citations. Previous affiliations of Andrew Kennedy include National Institute for Health Research.

Papers
More filters
Journal ArticleDOI

Large-scale community echocardiographic screening reveals a major burden of undiagnosed valvular heart disease in older people: the OxVALVE Population Cohort Study

TL;DR: A cross-sectional analysis of the clinical and epidemiological characteristics of VHD identified at recruitment of a large cohort of older people confirms the scale of the emerging epidemic of V HD, with widespread implications for clinicians and healthcare resources.
Journal ArticleDOI

Cardiac auscultation poorly predicts the presence of valvular heart disease in asymptomatic primary care patients.

TL;DR: Cardiac auscultation has limited accuracy for the detection of VHD in asymptomatic patients and is a poor diagnostic screening tool in primary care, particularly for overweight subjects.
Journal ArticleDOI

Community prevalence, mechanisms and outcome of mitral or tricuspid regurgitation.

TL;DR: In this paper, the authors identify the community prevalence of moderate or greater mitral or tricuspid regurgitation (MR/TR), and compare subjects identified by population screening with those with known valvular heart disease (VHD), to understand the mechanisms of MR/TR and to assess the rate of valve intervention and long-term outcome.
Journal ArticleDOI

136 Gp auscultation for diagnosing valvular heart disease

TL;DR: GP auscultation has only moderate accuracy for diagnosing valvular heart disease in an unselected population, and the presence of an isolated murmur would not be a reliable indicator of valve disease.
Journal ArticleDOI

Disease progression of heart failure in type 2 diabetes patients in Germany; a real world data analysis using health insurance claims data

TL;DR: This analysis provides disease progression insights in T2D patients who developed HF in Germany by measuring how many T2DM patients acquire HF over two years and understanding the progression of HF in these patients in a five-year follow-up.